Tata Chemicals Limited (BOM:500770)
India · Delayed Price · Currency is INR 735.25
-11.35 (-1.52%)
At close: Jun 15, 2026
Tata Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 145,840 | 148,870 | 154,210 | 167,890 | 126,220 | |
Revenue Growth (YoY) | -2.04% | -3.46% | -8.15% | 33.01% | 23.75% |
Cost of Revenue | 55,340 | 59,450 | 61,060 | 68,640 | 51,970 |
Gross Profit | 90,500 | 89,420 | 93,150 | 99,250 | 74,250 |
Selling, General & Admin | 51,820 | 48,990 | 42,800 | 40,600 | 34,660 |
Other Operating Expenses | 20,250 | 20,560 | 20,870 | 19,530 | 15,860 |
Operating Expenses | 84,100 | 80,800 | 73,580 | 69,080 | 58,760 |
Operating Income | 6,400 | 8,620 | 19,570 | 30,170 | 15,490 |
Interest Expense | -5,040 | -4,740 | -4,300 | -3,250 | -2,270 |
Interest & Investment Income | 1,720 | 1,130 | 1,900 | 1,160 | 1,410 |
Earnings From Equity Investments | 1,670 | 1,540 | 680 | -20 | 2,260 |
Currency Exchange Gain (Loss) | 220 | 50 | -470 | -300 | -70 |
Other Non Operating Income (Expenses) | -670 | -710 | -870 | -740 | -660 |
EBT Excluding Unusual Items | 4,300 | 5,890 | 16,510 | 27,020 | 16,160 |
Merger & Restructuring Charges | - | -1,250 | - | - | -110 |
Impairment of Goodwill | -18,370 | - | - | - | - |
Gain (Loss) on Sale of Investments | 520 | 510 | 490 | 570 | 580 |
Gain (Loss) on Sale of Assets | 130 | 40 | -30 | 20 | -140 |
Asset Writedown | - | - | -9,720 | -300 | - |
Legal Settlements | - | - | 1,020 | - | - |
Other Unusual Items | -1,190 | - | - | - | - |
Pretax Income | -14,590 | 5,210 | 8,300 | 27,400 | 16,670 |
Income Tax Expense | 2,560 | 1,670 | 3,810 | 2,880 | 2,670 |
Earnings From Continuing Operations | -17,150 | 3,540 | 4,490 | 24,520 | 14,000 |
Earnings From Discontinued Operations | - | 330 | -140 | -180 | 50 |
Net Income to Company | -17,150 | 3,870 | 4,350 | 24,340 | 14,050 |
Minority Interest in Earnings | -1,810 | -1,520 | -1,670 | -1,170 | -1,470 |
Net Income | -18,960 | 2,350 | 2,680 | 23,170 | 12,580 |
Net Income to Common | -18,960 | 2,350 | 2,680 | 23,170 | 12,580 |
Net Income Growth | - | -12.31% | -88.43% | 84.18% | 390.70% |
Shares Outstanding (Basic) | 255 | 255 | 255 | 255 | 255 |
Shares Outstanding (Diluted) | 255 | 255 | 255 | 255 | 255 |
EPS (Basic) | -74.42 | 9.22 | 10.52 | 90.95 | 49.38 |
EPS (Diluted) | -74.42 | 9.22 | 10.52 | 90.95 | 49.38 |
EPS Growth | - | -12.31% | -88.43% | 84.18% | 390.70% |
Free Cash Flow | 640 | -2,440 | 11,820 | 13,930 | 3,680 |
Free Cash Flow Per Share | 2.51 | -9.58 | 46.40 | 54.68 | 14.45 |
Dividend Per Share | 11.000 | 11.000 | 15.000 | 17.500 | 12.500 |
Dividend Growth | - | -26.67% | -14.29% | 40.00% | 25.00% |
Gross Margin | 62.05% | 60.07% | 60.41% | 59.12% | 58.83% |
Operating Margin | 4.39% | 5.79% | 12.69% | 17.97% | 12.27% |
Profit Margin | -13.00% | 1.58% | 1.74% | 13.80% | 9.97% |
Free Cash Flow Margin | 0.44% | -1.64% | 7.66% | 8.30% | 2.92% |
EBITDA | 16,630 | 18,340 | 28,110 | 39,050 | 23,500 |
EBITDA Margin | 11.40% | 12.32% | 18.23% | 23.26% | 18.62% |
D&A For EBITDA | 10,230 | 9,720 | 8,540 | 8,880 | 8,010 |
EBIT | 6,400 | 8,620 | 19,570 | 30,170 | 15,490 |
EBIT Margin | 4.39% | 5.79% | 12.69% | 17.97% | 12.27% |
Effective Tax Rate | - | 32.05% | 45.90% | 10.51% | 16.02% |
Revenue as Reported | 149,000 | 151,120 | 157,070 | 170,070 | 128,780 |
Advertising Expenses | 940 | 1,000 | 1,100 | 1,350 | 770 |